Novo Nordisk partners with Microsoft to accelerate drug discovery and development using big data and artificial intelligence Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and other rare blood disorders Saxenda ® obesity sales at an all-time high 3/2022 • SHARE Magazine 3
Download PDF file